Calling all veterinarians interested in FCGS treatment – Dr. Boaz Arzi (the PI for our DentaHeal FCGS clinical trial), in collaboration with the Winn Feline Foundation, will present a webinar on FCGS and share updates and future perspectives on FCGS treatment options – including stem cells.
About the webinar:
Feline chronic gingivostomatitis (FCGS), a severe inflammatory oral disease of cats is characterized by oral inflammation affecting the gingival and non-gingival mucosa. In the past 10 years, several key studies paved the road towards better understanding of the etiopathogenesis of FCGS and improving treatment options. This discussion will focus on recent discoveries in both etiopathogenesis and therapeutic options including stem cell therapy and immune modulation. Moreover, with the emerging field of regenerative medicine, this lecture will inform the practitioners on the practicability of stem cell therapy for FCGS. Finally, a path from current discoveries towards clinical applications will be discussed. Dr. Boaz Arzi is a Professor of Dentistry and Oral surgery at the department of Surgical and Radiological Sciences, UC Davis School of Veterinary Medicine. He is a Diplomate of the American Veterinary Dental College (AVDC) and the European Veterinary Dental College (EVDC). Dr. Arzi is also a Founding Fellow of the AVDC in Oral and Maxillofacial Surgery. Dr. Arzi’s clinical and research focus is on oral maxillofacial disorders and regenerative solutions in dogs and cats. His lab also investigates TMJ disorders and treatments across species. Dr. Arzi is the director of the Veterinary Institute for Regenerative Cures (VIRC) at UC Davis. Ultimately, Dr. Arzi’s work is translational with the aim of One Health treatment modalities for both human and animal health.
Click here to register for the Winn Feline Foundation webinar, which takes place January 13, 2021 at 10:00am PT.